US 9,042,448 · Application 12/995,039 · Granted May 26, 2015
US 9,042,448
Moving picture encoding system, moving picture encoding method, moving picture encoding program, moving picture decoding system, moving picture decoding method, moving picture decoding program, moving picture reencoding sytem, moving picture reencoding method, and
Estimated expiration
May 31, 2032
5y 221d remaining
- Could not fetch continuity data for application PCTJP2009059801: Resource not found (404)
Earliest effective filing
May 28, 2009
+ 20 years
May 28, 2029
PTA +1099d
May 31, 2032
No TD
—
Final
May 31, 2032
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- November 29, 2010
- Earliest effective filing
- May 28, 2009
- Issue date
- May 26, 2015
- PTA
- +1099 days
- Base expiry (before PTA)
- May 28, 2029
May 28, 2009 + 20 years = May 28, 2029 + 1099 PTA days = May 31, 2032
- National stage entry of application PCTJP2009059801, filed May 28, 2009
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/995,039 · US 9,042,448
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,042,448: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9042448Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.